Company: AIRJW
Filing Date: 2025-05-05
Form Type: 424B3
Source: 0001213900-25-039770
Chunk: 216

Company: AirJoule Technologies Corp.
Filing Date: 2025-05-05
Form: 424B3
Chunk 216
---
 380,771 Class A common stock, as converted, for a total
purchase price of $45,760.

As part of XPDB’s initial public offering
(“IPO”), XPDB issued 14,375,000 warrants to 37 third-party investors where each whole warrant entitles the holder to
purchase one share of the Company’s Class A common stock at an exercise price of $11.50 per share (the “Public Warrants”).
Simultaneously with the closing of the IPO, XPDB completed the private sale of 11,125,000 warrants where each warrant allows the
holder to purchase one share of the Company’s Class A common stock at $11.50 per share. In June 2024, 10 third-party investors
exercised their Public Warrants on a cashless basis for a total of 705,758 Class A shares of the Company. In August 2024, 2,225,000
Private Placement warrants were transferred.

As of December 31, 2024, there are 12,657,596
Public Warrants and 8,900,000 Private Placement warrants outstanding.

The Private Placement Warrants (including the
common stock issuable upon exercise of the Private Placement Warrants) were not transferable, assignable or saleable until 30 days
after the consummation of the Business Combination (except, among other limited exceptions, to the Company’s officers and directors
and other persons or entities affiliated with the XPDB’s sponsor and anchor investors) and they will not be redeemable by the
Company. The Private Placement Warrants have terms and provisions that are identical to those of the Public Warrants, including as to
exercise price, exercisability and exercise period, except that the Private Placement Warrants are exercisable on a cashless basis and
are non-redeemable.

If holders of the Private Placement Warrants elect
to exercise them on a cashless basis, they would pay the exercise price by surrendering their warrants for that number of shares of the Company’s
common stock equal to the quotient obtained by dividing (x) the product of the number of shares of the Company’s common
stock underlying the warrants multiplied by the excess of the 10 day average closing price (defined below) as of the date prior to
the date on which notice of exercise is sent or given to the warrant agent, less the warrant exercise price by (y) the 10 day
average closing price. The